These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 37195168)

  • 1. Synergistic Interactions among
    Lauman P; Dennis JJ
    Microbiol Spectr; 2023 Jun; 11(3):e0443022. PubMed ID: 37195168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Phage Therapy: Targeting the
    Lauman P; Dennis JJ
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage.
    Roszniowski B; Latka A; Maciejewska B; Vandenheuvel D; Olszak T; Briers Y; Holt GS; Valvano MA; Lavigne R; Smith DL; Drulis-Kawa Z
    Appl Microbiol Biotechnol; 2017 Feb; 101(3):1203-1216. PubMed ID: 27770178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.
    Kamal F; Dennis JJ
    Appl Environ Microbiol; 2015 Feb; 81(3):1132-8. PubMed ID: 25452284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cangene gold medal award lecture - Genomic analysis and modification of Burkholderia cepacia complex bacteriophages.
    Lynch KH; Dennis JJ
    Can J Microbiol; 2012 Mar; 58(3):221-35. PubMed ID: 22339239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkholderia contaminans Bacteriophage CSP3 Requires O-Antigen Polysaccharides for Infection.
    Stanton CR; Batinovic S; Petrovski S
    Microbiol Spectr; 2023 Jun; 11(3):e0533222. PubMed ID: 37199610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex.
    Lynch KH; Stothard P; Dennis JJ
    BMC Genomics; 2010 Oct; 11():599. PubMed ID: 20973964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophage steering of
    Ruest MK; Supina BSI; Dennis JJ
    J Bacteriol; 2023 Oct; 205(10):e0019623. PubMed ID: 37791751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosa to transducing bacteriophages.
    Nzula S; Vandamme P; Govan JR
    FEMS Immunol Med Microbiol; 2000 Aug; 28(4):307-12. PubMed ID: 10891654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysogeny and bacteriophage host range within the Burkholderia cepacia complex.
    Langley R; Kenna DT; Vandamme P; Ure R; Govan JRW
    J Med Microbiol; 2003 Jun; 52(Pt 6):483-490. PubMed ID: 12748267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing the Diversity of
    Nordstrom HR; Griffith MP; Rangachar Srinivasa V; Wallace NR; Li A; Cooper VS; Shields RK; Van Tyne D
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474392
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolation of a PRD1-like phage uncovers the carriage of three putative conjugative plasmids in clinical Burkholderia contaminans.
    Stanton CR; Petrovski S; Batinovic S
    Res Microbiol; 2024; 175(5-6):104202. PubMed ID: 38582389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burkholderia cepacia complex infections: More complex than the bacterium name suggest.
    Sfeir MM
    J Infect; 2018 Sep; 77(3):166-170. PubMed ID: 30012345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex.
    Seed KD; Dennis JJ
    Antimicrob Agents Chemother; 2009 May; 53(5):2205-8. PubMed ID: 19223640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections.
    Semler DD; Lynch KH; Dennis JJ
    Front Cell Infect Microbiol; 2011; 1():27. PubMed ID: 22919592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between Viral Regulatory Proteins Ensure an MOI-Independent Probability of Lysogeny during Infection by Bacteriophage P1.
    Zhang K; Pankratz K; Duong H; Theodore M; Guan J; Jiang AA; Lin Y; Zeng L
    mBio; 2021 Oct; 12(5):e0101321. PubMed ID: 34517752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.
    Semler DD; Goudie AD; Finlay WH; Dennis JJ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4005-13. PubMed ID: 24798268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage Milagro: a platform for engineering a broad host range virulent phage for
    Yao G; Le T; Korn AM; Peterson HN; Liu M; Gonzalez CF; Gill JJ
    J Virol; 2023 Nov; 97(11):e0085023. PubMed ID: 37943040
    [No Abstract]   [Full Text] [Related]  

  • 19. The Mla Pathway Plays an Essential Role in the Intrinsic Resistance of Burkholderia cepacia Complex Species to Antimicrobials and Host Innate Components.
    Bernier SP; Son S; Surette MG
    J Bacteriol; 2018 Sep; 200(18):. PubMed ID: 29986943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny.
    Al-Anany AM; Fatima R; Nair G; Mayol JT; Hynes AP
    mBio; 2024 Jun; 15(6):e0050424. PubMed ID: 38757974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.